Experts recommend Covaxin for phase 2/3 trials on 2 to18 years old

12-05-2021 Wed 09:36
advertisement

Hyderabad-based Bharat Biotech's COVID-19 vaccine Covaxin was recommended by an expert panel for conducting phase 2/3 clinical trials to evaluate the safety on those aged between two to 18 years. According to the reports, the proposal was deliberated in the Subject Expert Committee (SEC) on Covid-19 of the Central Drugs Standard Control Organisation (CDSCO) meeting dated February 24 and the firm was asked to submit a revised clinical trial protocol. Reports suggest that the clinical trial will take place at AIIMS-Delhi, AIIMS-Patna, and Meditrina Institute of Medical Sciences at Nagpur.

advertisement

More Video News
advertisement
..more
advertisement